Nexus BioQuest
Bristol, United Kingdom nexusbioquest.com From their website, Nov 2026
Work here? Claim this listing
About
Nexus BioQuest is a contract research organisation focused on immunology and pre-clinical drug discovery. It works with pharmaceutical and biotech clients on assay design, drug discovery, biomarker work, and proteomics for immune-focused therapeutic programs. The company is based in Portishead, Bristol, United Kingdom, with a registered office in London.
Services
Bespoke Assay Design
Designs and customises immunology assays for drug discovery programmes, including consultation, study design, assay optimisation, and execution.
Drug Discovery
Provides preclinical and non-regulatory clinical drug discovery support from target validation through lead optimisation and candidate selection using human-relevant immune assays.
Clinical Biomarker Services
Delivers preclinical biomarker development and non-regulatory clinical biomarker services, including cellular, analytical, and functional biomarker assays.
Predictive Immunotoxicology
Offers immunotoxicology services to assess cytokine release risk and off-target immune effects for biologics, cell therapies, and gene therapies.
ADME, DMPK & toxicology
Omycx Proteomics
Uses high-dimensional proteomics to compare healthy and disease biology in human-relevant models and generate therapeutic signatures for translational decision making.
Proteomics / Omycx
Uses proteomics to compare healthy and disease biology in human-relevant models and evaluate how therapeutics modify proteomic signatures.
- Turnaround
- Quotes for our standard assays will be sent within 24-48 hours
- What to send
- 1 µL of sample
- 1 µL sample
- Cell culture supernatant
Capabilities
- Assays and studies
- Small molecules
- Flow cytometry
- Toxicology
- qPCR
- Cell therapy
- Immune-oncology assays
14 more
- Autoimmune assays
- Inflammation assays
- Neuroinflammation assays
- Target validation assays
- Mechanistic studies
- Translational research
- Gene knockout functional assays
- Pathway inhibition assays
- Biomarker assays
- Proteomics
- Direct pathway inhibition assays
- Ex vivo assays
- Proteomic profiling
- Mixed lymphocyte reaction (MLR)
- Scale and capacity
- 1 µL sample volume required
- Disease focused panels of 45 or 92 analytes
- Therapeutic areas
- Immune-oncology
- Autoimmunity
- Inflammation
- Hypersensitivity
- Neuroinflammation
- Oncology
3 more
- Fibrosis
- Inflammation and Hypersensitivity
- Neuro Inflammation
Instruments and platforms
- Olink proteomics
- Meso Scale Discovery (MSD)
- NovoCyte Penteon
- Flow cytometry
- qPCR
- Olink proximity extension assay technology
- Olink PEA
Modalities and species
- Modalities
- Small molecule
- Cell therapy
- Vaccine
- Species and models
- Human primary cells
- Human iPSC-based models
- Patient material
- Relevant cell lines
- Healthy donor cells
- Diseased donor cells
5 more
- Secondary lymphoid organ ex vivo model
- Mixed lymphocyte reaction (MLR)
- Established cell lines
- Healthy donors
- Diseased donors
Industries served
- Biotech
Company
- Type
- CRO
Locations
- Address
- 10 Portis Field Bristol Road Portishead Bristol BS20 6PN
- Sites
- London, United Kingdom
- Serves
- United Kingdom
Contacts
- General enquiry
- team@nexusbioquest.com on their site
- General enquiry
- info@nexusbioquest.com on their site
- Phone
- 01275 840029